| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 37.5824 | 2 |
| GSM780708 | Untreated after 4 days (C2_1) | 42.0538 | 13 |
| GSM780709 | Untreated after 4 days (C3_1) | 37.8247 | 2 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.6824 | 30 |
| GSM780720 | Untreated after 4 days (C2_2) | 38.2916 | 3 |
| GSM780721 | Untreated after 4 days (C3_2) | 41.9279 | 13 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 40.3027 | 7 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.2233 | 28 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.0033 | 17 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 38.5185 | 3 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.4086 | 19 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 38.1517 | 3 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.0838 | 13 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.7043 | 26 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.4227 | 15 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 40.4103 | 8 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.2595 | 23 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 35.9544 | 1 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 35.5774 | 1 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.183 | 14 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 40.5847 | 8 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 43.5814 | 20 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.1889 | 23 |